Terms or Use

Home

Company

Technology

Careers

Contact

Investors

Join our newsletter to stay up to date on features and releases.

We care about your data in our privacy policy.

Thank you! Your submission has been received!

Oops! Something went wrong while submitting the form.

Corporate Contact

3913 Todd Ln #307
Austin, TX 78744
Phone: 512-790-5151
info@monogramorthopedics.com

Investor Relations

MZ North America
Chris Tyson
Executive Vice President
Phone: 949-491-8235
MGRM@mzgroup.us

This website may include ''forward-looking statements.'' To the extent that the information presented in this presentation discusses financial projections, information, or expectations about Monogram Technologies Inc.’s business plans, results of operations, products or markets, or otherwise makes statements about future events, such statements are forward-looking. Such forward-looking statements can be identified by the use of words such as ''should,'' ''may,'' ''intends,'' ''anticipates,'' ''believes,'' ''estimates,'' ''projects,'' ''forecasts,'' ''expects,'' ''plans,'' and ''proposes.''Although Monogram Technologies Inc. (“Monogram”) believes that the expectations reflected in these forward-looking statements are based on reasonable assumptions, there are a number of risks and uncertainties that could cause actual results to differ materially from such forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" and elsewhere in the offering statement filed with the SEC. Forward-looking statements speak only as of the date of the document in which they are contained, and Monogram does not undertake any duty to update any forward-looking statements except as may be required by law.The securities offered by Monogram are highly speculative. Each unit consisting of one share of 8.00% Series D Convertible Cumulative Preferred Stock and one Common Stock Purchase Warrant. The units have no stand-alone rights and will not be certified or issued as stand-alone securities. Investing in these Monogram securities involves significant risks. The investment is suitable only for persons who can afford to lose their entire investment. Furthermore, investors must understand that such investment could be illiquid for an indefinite period of time. There is no existing public trading market for the Series D Preferred Stock. We do not intend to apply for listing of the Series D Preferred Stock or the common stock purchase warrants on a national securities exchange or quoted on an over the counter market. The offering is being made pursuant to an effective shelf registration that has been filed with the U.S. Securities and Exchange Commission (the “SEC”). The final prospectus supplement relating to the offering was filed with the SEC and is available on the SEC’s website at https://www.sec.gov/

Terms of Use

Terms of Use